2007
DOI: 10.1016/j.gie.2006.06.083
|View full text |Cite
|
Sign up to set email alerts
|

Pancreatic-fluid collections: a randomized controlled trial regarding stent removal after endoscopic transmural drainage

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

6
197
0
4

Year Published

2007
2007
2018
2018

Publication Types

Select...
5
4

Relationship

0
9

Authors

Journals

citations
Cited by 260 publications
(207 citation statements)
references
References 38 publications
6
197
0
4
Order By: Relevance
“…Furthermore, as shown in a subgroup analysis in this study, even when a PD stent is successfully placed across the leak/disruption in patients who undergo CD, there was no difference in treatment outcomes when compared with patients who underwent TM alone. Thus, although there is a paucity of studies that have directly evaluated PD disruption and healing after TM alone, the positive clinical outcomes associated with PFC resolution and low recurrence rates would suggest this to be an effective treatment modality in most patients with PD disruption, including those with a disconnected pancreatic duct syndrome [27,28]. Altogether, the low technical success rate of TP, the well-recognized potential adverse events associated with ERP, and the absence of definitive improved treatment outcomes with a combined drainage approach, suggests that TP has no benefit in patients with pseudocysts undergoing endoscopic TM.…”
Section: Accepted Manuscriptmentioning
confidence: 99%
“…Furthermore, as shown in a subgroup analysis in this study, even when a PD stent is successfully placed across the leak/disruption in patients who undergo CD, there was no difference in treatment outcomes when compared with patients who underwent TM alone. Thus, although there is a paucity of studies that have directly evaluated PD disruption and healing after TM alone, the positive clinical outcomes associated with PFC resolution and low recurrence rates would suggest this to be an effective treatment modality in most patients with PD disruption, including those with a disconnected pancreatic duct syndrome [27,28]. Altogether, the low technical success rate of TP, the well-recognized potential adverse events associated with ERP, and the absence of definitive improved treatment outcomes with a combined drainage approach, suggests that TP has no benefit in patients with pseudocysts undergoing endoscopic TM.…”
Section: Accepted Manuscriptmentioning
confidence: 99%
“…They help in delineation of the anatomy and PFC. With expertise PFCs that have failed drainage by other methods and those in unusual locations are also considered for drainage [7,16,23] . Many experts recommend assessment of the main pancreatic duct at the time of PFC drainage with ERCP as uniden- tified pancreatic duct stricture or leak may result in failure of resolution or recurrence of PFC [16,24,25] .…”
Section: Prerequisites For Eus Drainagementioning
confidence: 99%
“…Patients needs follow up on four weekly basis with cross sectional imaging. All the stents can be removed after confirmation of the resolution of collection and after ensuring the integrity of pancreatic duct [23] . We routinely remove stent at three months and SEMS at 8 wk.…”
Section: Review Of Literaturementioning
confidence: 99%
“…A randomised trial suggested that long-term transenteric stenting in patients with disconnected pancreatic duct syndrome may be an alternative to surgery to prevent the recurrence of collection. (29) However, more data would be required to confirm this finding, given the concerns regarding stent occlusion and infection.…”
Section: Methodsmentioning
confidence: 91%